Efficacy of Vasakadi Ghan Vati in Hypertensive Retinopathy
- Conditions
- Health Condition 1: H350- Background retinopathy and retinalvascular changes
- Registration Number
- CTRI/2019/02/017599
- Lead Sponsor
- R A Podar Medical Ayurvedic College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
1)Willing to give written consent to participate in the study.
2)Age 20-70 years.
3)Both sexes.
4)Known patient of essential hypertension presenting signs of hypertensive retinopathy on fundal examination.
5)Subject with hypertensive retinopathy: Keith Wegner Barker Grade 1, 2 and 3.
6)Subject with systolic blood pressure less than 180 mm of Hg. and diastolic blood pressure less than 120 mm of Hg.
7)Hypertensive patient complaining of dimness of vision.
1)Age less than 20 years and more than 70 years.
2)Secondary hypertension and Severe or stage • hypertension (Blood pressure more than equal to 180/110 mm of Hg.)
3)Presence of fundus alteration which did not result from arterial hypertension.
4)Presence of cardio-vascular disease other than hypertension and collagen disease.
5)Presence of hypertensive emergencies and urgencies (diastolic blood pressure more than equal to 130 mm of Hg. or severe blood pressure with target organ damage.)and hypertension related disorders.
6)Diabetes mellitus.
7)Thyroid disease.
8)Current abuse of alcohol or other drug.
9)Mental incapacitance.
10)Unwillingness.
11)Dropouts.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To see the effect of Vasakadi Ghan Vati in arteriosclerotic changes , exudates and haemorrhages seen in hypertensive retinopathy.Timepoint: 1.To see the effect of Vasakadi Ghan Vati in arteriosclerotic changes , exudates and haemorrhages seen in hypertensive retinopathy by the end of 3 months.
- Secondary Outcome Measures
Name Time Method 1.To stabilise or improve visual acuity lost due to hypertensive retinopathy. <br/ ><br>2.To study the changes in the bio-chemical parameters in the patients with hypertensive retinopathy after administration of Vasakadi Ghan Vati for three months. <br/ ><br>3.To study adverse and safety events related with Vasakadi Ghan Vati. <br/ ><br>Timepoint: End of 3 Months